| Literature DB >> 28359144 |
Kyeong-Won Yoo1, Maivannan Thiruvarangan1, Yun-Mi Jeong1, Mi-Sun Lee1, Sateesh Maddirevula1, Myungchull Rhee1, Young-Ki Bae2, Hyung-Goo Kim3, Cheol-Hee Kim1.
Abstract
Ran-binding proteimical">n family member,Entities:
Keywords: RanBP9; mind bomb; notch; retinogenesis; zebrafish
Mesh:
Substances:
Year: 2017 PMID: 28359144 PMCID: PMC5424273 DOI: 10.14348/molcells.2017.2308
Source DB: PubMed Journal: Mol Cells ISSN: 1016-8478 Impact factor: 5.034
Fig. 1Isolation of RanBP9 as a Mib-binding protein from yeast two-hybrid screening.
(A) Schematic representation of Mib bait and RanBP9 prey proteins. The Mib bait contains the middle region of ankyrin repeats from amino acids 410 to 744. Multiple clones of RanBP9 prey were identified. Here, RanBP9 polypeptides starting from 136th or 158th amino acid were represented. (B) Protein sequence alignment between human, mouse and zebrafish RanBP9 homologues. (C) Comparison of domain similarity (%) between human and zebrafish RanBP9. PRD, proline-rich domain; SPRY, domain in sp1A and Ryanodine receptor; LisH, Lissencephaly type-1-like homology motif; CTLH, C-Terminal to the LisH; and a CRA motif.
Fig. 2Spatiotemporal expression of ranbp9 mRNA during embryonic development.
Whole-mount in situ hybridization was performed with DIG-labeled antisense RNA probe (hpf, hours after fertilization). (A) At 2-cell stage, maternal transcripts were detected in high density. (B) At dome stage (4 hpf), high level of transcription persisted. (C) At the beginning of gastrulation, shield stage (6 hpf), ranbp9 mRNA was hardly detected. (D) At 6-somite stage (12 hpf), ranbp9 was seen expressed ubiquitously. (E) At 48 hpf, ranbp9 expression was mainly observed in the head region. (F) Section of head region at 72 hpf, showing ranbp9 expression in the brain (B) and eye (L, lens). Its expression is more prominent in forming layers (arrow head) of the retina, compared to the periphery (arrow). O, oral cavity.
Fig. 3Physical interaction between RanBP9 and Mib.
(A) Each cell lysate transfected with a combination of expression vectors was pulled down with anti-Myc antibody and the western blot was stained with anti-Myc antibody. Top panels show lysates without co-immunoprecipitation. (B) Cell lysates were pulled down with anti-Myc antibody and the western blot was stained with anti-Frag antibody. ta52b (M1013R) and tfi101 (C1009S) are mutant forms of Mib, having point mutation in the 3rd ring finger. Moe was used as a positive control for Mib binding. Arrows indicate the size for Frag-Mib and Frag-Mib/ta52b.
Fig. 4Subcellular co-localization of RanBP9 and Mib in COS7 cells.
COS7 cells were transiently transfected with expression vectors encoding Mib-GFP and HA-RanBP9. (A) Mib-GFP was detected in the cytoplasm in a punctuate pattern. (B) HA-RanBP9 was localized in a similar punctuate pattern in the cytoplasm, in addition to its localization in the nucleus. Transfected cells were fixed and stained with anti-HA antibody. The yellow color and arrows in the merged image in (C) indicate co-localization of Mib and RanBP9 in the cytoplasmic punctuate structures. Hoechst dye staining (blue) shows the nucleus.
Fig. 5Genomic structure of ranbp9 and design of antisense morpholino to block the pre-mRNA splicing.
(A) 14 exons of ranbp9 gene was stretched for 20 kb on the genome. The target junction is the splicing donor site at Ex4:Int4. (B) Diagram illustrating the process of interference with premature mRNA splicing. Enlargement of the grey boxed area in (A). Arrows in (B) indicate the locations of primers used for the PCR analysis. (C) Predicted proteins encoded by the normal and morphant transcripts. Truncated RanBP9 was produced by an induced stop codon. (D) RT-PCR analysis for the efficacy of antisense morpholino. Abnormal transcripts in the morphant embryos were detected (823 bp, compared to 611 bp wild-type). The efficacy gradually decreased at later stages. (E) The truncated RanBP9 was confirmed by sequencing of morphant transcripts.
Fig. 6Defects in the brain and retina of ranbp9-MO injected zebrafish embryos.
(A) Control (Cont) and ranbp9-MO injected (MO) zebrafish larvae at 5 dpf. Compared to normal development of body trunk region, reduced size of brain and eye was observed in the MO injected larva. Asterisk indicates swim-bladder. (B) By acridine orange staining, a specific cell death was detected in the brain tectum of 54 hpf morphants. (C) Disruption of retinal development in ranbp9 morphant. Section of HE-stained retina in control and ranbp9 morphant at 73 hpf. In wild-type, the retina was established into several layers; 1, ganglion cell layer: 2, inner plexiform layer: 3, inner nuclear layer: 4, outer plexiform layer: 5, outer nuclear layer: and 6, photoreceptor cell layer, respectively. In morphants, however, these layer formations were not well established.
Fig. 7Molecular characterization of retinal development in ranbp9 morphants.
(A) Whole-mount in situ hybridization analysis for the expression of neural markers; huC for neuronal differentiation marker and her4 for neural progenitor marker, respectively. The neurogenic mutant mind bomb (mib, −/−) was used for comparison. In the WT larvae at 48 hpf, huC was expressed in the apical cells of the retina, but her4 was expressed in the basal cells. In the mib mutant larvae, huC was seen stained in most of the retinal cells near the apico-basal axis, but her4-positive cells were not observed. In the ranbp9 morphant larvae, huC expression domain was significantly reduced, however, the her4 expression domain was expanded. (B) Altered-regulation of p57kip2, a molecular marker for cell cycle exit, in ranbp9 morphants. p57kip2 transcripts were observed in the peripheral marginal regions of wild-type retina, while its expression was expanded to the central region of retina in ranbp9 morphants.
Fig. 8Characterization of glial cells in ranbp9 morphants.
Retinal sections were stained with an antibody against Glutamine synthetase, which is used as a molecular marker for the Müller glia cells. Glial cell differentiation is also affected in ranbp9 morphants (MO), compared to that of control retina. Hoechst staining and bright field image were shown for the comparison of retinal structures.